BenevolentAI
computational and experimental platform enables novel discoveries and improved decision making experimental validation knowledge graph user interface tools predictive algorithms used to extract and infer new information at scale leading covid treatment cation of via work searching for approved drugs inhibiting signalling and in less than approach validated in high quality peer publications including nature novel target for ulcerative colitis which has zero linkage to in all of available literature | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
14 of 42
Related slides by other companies
Advantage Solutions
Investor Presentation
August 2023
the basics what advantage does essential partner to leading brands and retailers helping clients reach consumers every day in store and through technology enabled sales and marketing solutions products shopper informed by data | Advantage Solutions
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io